Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EVX-02 by Evaxion Biotech for Melanoma: Likelihood of Approval
EVX-02 is under clinical development by Evaxion Biotech and currently in Phase II for Melanoma. According to GlobalData, Phase II...